IP Library Assignment 054734/0660
Patent Assignment
Reel/Frame 054734/0660

Assignment of Assignor's Interest

Recorded: 2020-12-22 Pages: 4
Assignor
KLEIN, CHRISTIAN
Executed: 2014-09-24
Assignee
ROCHE GLYCART AG
WAGISTRASSE 18, SCHLIEREN, 8952, SWAZILAND
Covered Properties (2)
Combination Therapy of a Type Ii Anti-CD20 Antibody with a Selective Bcl-2 Inhibitor
Application: 15/365,595 →
Publication: US 2017/0281619
Combination Therapy of a Type Ii Anti-CD20 Antibody with a Selective Bcl-2 Inhibitor
Application: 16/827,650 →
Publication: US 2020/0253963
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 22, 2020
From: SAMPATH, DEEPAK; FAIRBROTHER, WAYNE JOHN
To: GENENTECH, INC.
Reel/Frame 054734/0650 →
Assignment of Assignor's Interest Dec 22, 2020
From: ROCHE GLYCART AG
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 054734/0670 →
Assignment of Assignor's Interest Jan 15, 2021
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 054938/0587 →
Assignment of Assignor's Interest Feb 2, 2021
From: GENENTECH, INC.
To: GENENTECH, INC.; ABBVIE INC.
Reel/Frame 055117/0984 →
Assignment of Assignor's Interest Feb 3, 2021
From: ROBERTS, ANDREW W.; SEYMOUR, JOHN F.
To: ABBVIE INC.
Reel/Frame 055138/0411 →
Assignment of Assignor's Interest Feb 5, 2021
From: HUMERICKHOUSE, ROD A.
To: ABBVIE INC.
Reel/Frame 055169/0208 →